Abingdon Health Repositions Leadership for US Expansion

Portfolio - People | Mar 24, 2025 | Business Cloud

Abingdon Health Repositions Leadership for US Expansion

Abingdon Health plc, a renowned player in the development, manufacture, and distribution of rapid tests, has announced significant changes in its leadership team. Chris Yates, who served as CEO for a decade, has been appointed as the president of Abingdon Health USA. Yates, who co-founded the company in 2008, will be responsible for overseeing the US operations and managing global commercial activities. The role of group CEO will be absorbed into Dr. Chris Hand's executive chairman role. Additionally, Dr. Katie Brenner joins the board as a non-executive director. The company is focusing on the US lateral flow and compliance markets, with a noted revenue increase to £3.1m for the six months ending December 2024. Despite revenue growth, operating costs increased due to investments in facilities in Doncaster and Madison, Wisconsin, resulting in an EBITDA loss of £1.9m.

Sectors

  • Healthcare
  • Medical Technology

Geography

  • United Kingdom – Abingdon Health is headquartered in York, UK, and the leadership changes are originating from the UK office.
  • United States – The company's strategic focus is increasingly on the US market, with new operations and leadership roles targeting this geography.

Industry

  • Healthcare – Abingdon Health operates within the healthcare sector, specializing in rapid diagnostic tests.
  • Medical Technology – The company's focus on rapid tests and recent appointments emphasizes its role in the MedTech industry.

Financials

  • 3.1m – Reported revenue for the six months to December 2024.
  • 1.9m – EBITDA loss reported for the same period.
  • 28.4% – Revenue growth rate compared to the previous year.
  • 3.2m – Operating costs, attributed to investments in new labs.

Participants

NameRoleTypeDescription
Abingdon Health plcTargetCompanyAn international MedTech company specializing in the development and distribution of rapid diagnostic tests.
Chris YatesFormer CEO, Current President of Abingdon Health USAPersonCo-founder of Abingdon Health, transitioning from CEO to President of US operations.
Dr. Chris HandExecutive ChairmanPersonCo-founder and former CEO, now taking on an expanded role as executive chairman.
Dr. Katie BrennerNon-Executive DirectorPersonNewly appointed to the board, bringing expertise in lateral flow testing and experience from her company bluDiagnostics.